Log on / register
Feedback | Support | My details

Pre-publication history

Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer

Maryse Lemaire email, Guy G Chabot email, Noël JM Raynal email, Louise F Momparler email, Annie Hurtubise email, Mark L Bernstein email and Richard L Momparler email

BMC Cancer 2008, 8:128doi:10.1186/1471-2407-8-128

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript01 Nov 2007
Reviewer's ReportAlexander Dobrovic29 Nov 2007
Reviewer's ReportQian Tao07 Jan 2008
Resubmission - Version 2ManuscriptAuthors' comments22 Jan 2008
Reviewer's ReportAlexander Dobrovic11 Feb 2008
Reviewer's ReportQian Tao11 Feb 2008
Resubmission - Version 3Manuscript20 Mar 2008
Resubmission - Version 4ManuscriptAuthors' comments01 May 2008
Accepted02 May 2008
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated